Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab + Trastuzumab + Chemo vs Trastuzumab + Chemo in Pretreated HER2+ MBC
NCT02229149Phase 2Terminated
- Sponsor
- US Oncology Network
- Start
- Dec 2014
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by US Oncology Network. Started Dec 2014; status: terminated.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02229149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229149.